We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+25.81%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$241M
AUM Growth
+$50.3M
Cap. Flow
+$11.8M
Cap. Flow %
4.88%
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17

Top Buys

Rank Stock Value
1
BEPC icon
Brookfield Renewable
BEPC
+$1.51M
2
WES icon
Western Midstream Partners
WES
+$926K
3
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$707K
4
DK icon
Delek US
DK
+$681K
5
CVI icon
CVR Energy
CVI
+$669K

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$1.61M
2
AIMT
Aimmune Therapeutics
AIMT
+$1.13M
3
AIV
Aimco
AIV
+$1.1M
4
VIV icon
Telefônica Brasil
VIV
+$1.01M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$988K

Sector Composition

Rank Sector Weight
1 Healthcare 29.53%
2 Real Estate 18.96%
3 Energy 16.61%
4 Materials 11.31%
5 Utilities 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCAP icon
351
Crescent Capital BDC
CCAP
$403M
$118K 0.05%
8,066
+1,241
+18% +$17K
LQD icon
352
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$116K 0.05%
840
– –
APRE icon
353
Aprea Therapeutics
APRE
$7.68M
$50K 0.02%
513
+11
+2% +$5.23K
EMB icon
354
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$47K 0.02%
+406
New +$46K
CCO icon
355
Clear Channel Outdoor Holdings
CCO
$1.23B
$11K ﹤0.01%
6,654
– –
AIV
356
Aimco
AIV
$387M
– –
-245,923
Closed -$1.1M
ASMB icon
357
Assembly Biosciences
ASMB
$498M
– –
-1,230
Closed -$243K
CNX icon
358
CNX Resources
CNX
$5.06B
– –
-1,290
Closed -$12K
CRBP icon
359
Corbus Pharmaceuticals
CRBP
$166M
– –
-1,487
Closed -$80K
OVID icon
360
Ovid Therapeutics
OVID
$414M
– –
-58,716
Closed -$337K
TVTX icon
361
Travere Therapeutics
TVTX
$5.2B
– –
-38,150
Closed -$704K
VIV icon
362
Telefônica Brasil
VIV
$20.6B
– –
-131,266
Closed -$1.01M
SGEN
363
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-3,867
Closed -$757K
DEN
364
DELISTED
Denbury Inc.
DEN
– –
-777
Closed -$14K
CLVS
365
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-86,459
Closed -$504K
MVC
366
DELISTED
MVC Capital, Inc.
MVC
– –
-27,393
Closed -$214K
MYOK
367
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-3,282
Closed -$447K
IMMU
368
DELISTED
Immunomedics Inc
IMMU
– –
-18,897
Closed -$1.61M
AIMT
369
DELISTED
Aimmune Therapeutics
AIMT
– –
-32,688
Closed -$1.13M
AKCA
370
DELISTED
Akcea Therapeutics Inc
AKCA
– –
-43,813
Closed -$795K
MNTA
371
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-18,823
Closed -$988K
WPG
372
DELISTED
Washington Prime Group Inc.
WPG
– –
-145,657
Closed -$849K
11 12 13 14
15

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM

Virtus ETF Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Virtus ETF Advisers held 372 positions worth $241M, up 26% from $191M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Virtus ETF Advisers deployed $11.8M of net new capital in Q4 2020, opening 47 new positions and adding to 146 existing holdings. Its largest new stake was Harmony Biosciences: 14,899 shares worth $539K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $572K trimmed.

  • Virtus ETF Advisers's largest Q4 2020 buy was Harmony Biosciences: 14,899 shares worth $539K.
  • Virtus ETF Advisers added most to Brookfield Renewable in Q4 2020, an estimated $1.51M increase.
  • Virtus ETF Advisers's biggest Q4 2020 reduction was Amicus Therapeutics, cutting an estimated $572K.
  • Virtus ETF Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $1.61M.
  • Virtus ETF Advisers's ten largest holdings make up 9.4% of its $241M portfolio in Q4 2020.
  • Virtus ETF Advisers opened 47 new positions and closed 17 in Q4 2020.
  • Virtus ETF Advisers's portfolio value rose 26% quarter-over-quarter to $241M.

Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.